MedRhythms, Inc.
StreetZero Signal 58
About MedRhythms, Inc.
MedRhythms, Inc. is a digital health company that develops wearable devices and a proprietary platform combining sensors, software, and music to deliver rhythmic auditory stimulation therapy. The therapy targets neural circuitry to improve walking ability and restore nervous system functioning for patients with neurological conditions such as stroke, multiple sclerosis, and Parkinson's disease. The company has received FDA Breakthrough Device designation for its chronic stroke walking deficits therapeutic. It is headquartered in Portland, Maine.
LATEST FUNDINGPrivate Placement
$250K
Announced 2026-10-13
TOTAL RAISED$65.06M
IN THE NEWS
- 🔗 MedRhythms - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Portland-based MedRhythms gets $25M in latest venture funding round
- 🔗 Portland-based MedRhythms gets $25M in latest venture funding round
- 🔗 MedRhythms - Products, Competitors, Financials, Employees, Headquarters Locations
- 🔗 MedRhythms - 2026 Funding Rounds & List of Investors - Tracxn
EMPLOYEES—
FOUNDED2013
HQPortland, ME, United States
Industry
Other Technology
Tags
Digital HealthNeurotechWearablesSeries B
Key highlights
- Raised $25M in Series B funding for its digital rhythmic auditory stimulation platform.
- Obtained FDA Breakthrough Device designation for chronic stroke walking deficits therapy.
- Total funding exceeds $64M from institutional investors including Morningside and Advantage Capital.
- Platform uses sensors, software and music to target neural circuitry for mobility recovery.
- Headquartered in Portland, Maine with products in development for stroke, MS and Parkinson's.
Ask StreetZero about MedRhythms, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account